Laboratory of Translational Medicine, Gachon University Lee Gil Ya Cancer and Diabetes Institute, Department of Gastroenterology, Gachon Graduate School of Medicine, Incheon, Korea.
J Gastroenterol Hepatol. 2010 Jan;25(1):194-202. doi: 10.1111/j.1440-1746.2009.06127.x.
In spite of the International Agency for Research on Cancer's definition that Helicobacter pylori is the definite carcinogen of gastric cancer, the simple eradication of the bug is not enough to prevent resultant gastric cancer, and increasing microbial resistance further limits the eradication application. Therefore, probiotics, non-pathogenic microbial feed that can affect the host in a beneficial manner, could be an alternate way to enhance anti-inflammation against H. pylori. However, the mechanism of their anti-inflammatory actions is still unclear. In the current study, we hypothesized that suppressor of cytokine signaling (SOCS) signaling could be a feasible anti-inflammatory mechanism of probiotics against H. pylori infection.
H. pylori infection or their lipopolysaccharide stimulation led to significant increased expressions of inflammatory mediators including tumor necrosis factor-alpha, interleukin-8, inducible nitric oxide synthase and cyclooxygenase-2 in AGS cells and pretreatment of Lactobacillus plantarum, Lactobacillus rhamnosis and Lactobacillus acidophilus significantly attenuated the expressions of these inflammatory mediators in accordance with the blocking action of nuclear factor-kappaB nuclear translocation. Probiotic administration increased expression of SOCS-2 and SOCS-3 and exerted the active SOCS signaling featured with earlier and higher expressions of SOCS-2 and SOCS-3. In contrast to weak inactivation of mitogen-activated protein kinases including p-38 and extracellular signal-regulated kinase 1/2, probiotic-induced SOCS expressions were mediated through either significant phosphorylation of signal transducers and activation of transcription (STAT)-1 and STAT-3 or simultaneous inhibition of Janus kinase (JAK)2 phosphorylation, which is known to signal SOCS-2/SOCS-3 negatively.
Anti-inflammatory signals of SOCS through STAT-1/STAT-3 activation and JAK2 inactivation might be a key anti-inflammatory mechanism of probiotics, setting probiotics as a non-microbial strategy to H. pylori infection.
尽管国际癌症研究机构将幽门螺杆菌定义为胃癌的明确致癌物,但单纯清除这种细菌并不能完全预防胃癌的发生,而微生物耐药性的增加进一步限制了其清除应用。因此,益生菌,即可以以有益方式影响宿主的非致病性微生物饲料,可能是增强抗幽门螺杆菌炎症的替代方法。然而,其抗炎作用的机制尚不清楚。在本研究中,我们假设细胞因子信号转导抑制剂(SOCS)信号可能是益生菌对抗幽门螺杆菌感染的一种可行的抗炎机制。
幽门螺杆菌感染或其脂多糖刺激导致 AGS 细胞中炎症介质(包括肿瘤坏死因子-α、白细胞介素-8、诱导型一氧化氮合酶和环氧化酶-2)的表达显著增加,而植物乳杆菌、鼠李糖乳杆菌和嗜酸乳杆菌的预处理显著减弱了这些炎症介质的表达,与核因子-κB 核转位的阻断作用一致。益生菌的使用增加了 SOCS-2 和 SOCS-3 的表达,并发挥了活跃的 SOCS 信号,表现为 SOCS-2 和 SOCS-3 的表达更早、更高。与丝裂原激活的蛋白激酶(包括 p38 和细胞外信号调节激酶 1/2)的弱失活相反,益生菌诱导的 SOCS 表达是通过信号转导和转录激活因子(STAT)-1 和 STAT-3 的显著磷酸化或同时抑制已知负向信号 SOCS-2/SOCS-3 的 Janus 激酶(JAK)2 磷酸化来介导的。
通过 STAT-1/STAT-3 激活和 JAK2 失活的 SOCS 抗炎信号可能是益生菌抗炎的关键机制,使益生菌成为对抗幽门螺杆菌感染的非微生物策略。